Q1 EPS Estimate for Solid Biosciences Boosted by Analyst
Solid Biosciences Inc. (NASDAQ:SLDB – Free Report) – Equities research analysts at Leerink Partnrs lifted their Q1 2025 EPS estimates for Solid Biosciences in a report released on Sunday, February 23rd. Leerink Partnrs analyst J. Schwartz now anticipates that the company will earn ($0.36) per share for the quarter, up from their prior estimate of […]
